IOBT
Price
$0.28
Change
-$0.25 (-47.17%)
Updated
Feb 3 closing price
Capitalization
20M
28 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$15.37
Change
+$5.99 (+63.86%)
Updated
Feb 3 closing price
Capitalization
1.12B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IOBT vs MLTX

Header iconIOBT vs MLTX Comparison
Open Charts IOBT vs MLTXBanner chart's image
IO Biotech
Price$0.28
Change-$0.25 (-47.17%)
Volume$1.92M
Capitalization20M
MoonLake Immunotherapeutics
Price$15.37
Change+$5.99 (+63.86%)
Volume$1.07M
Capitalization1.12B
IOBT vs MLTX Comparison Chart in %
IOBT
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IOBT vs. MLTX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBT is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IOBT: $0.28 vs. MLTX: $15.79)
Brand notoriety: IOBT and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOBT: 13% vs. MLTX: 61%
Market capitalization -- IOBT: $20M vs. MLTX: $1.12B
IOBT [@Biotechnology] is valued at $20M. MLTX’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBT’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • IOBT’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than IOBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOBT’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • IOBT’s TA Score: 4 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IOBT is a better buy in the short-term than MLTX.

Price Growth

IOBT (@Biotechnology) experienced а -10.38% price change this week, while MLTX (@Biotechnology) price change was -0.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was +36.66%.

Reported Earning Dates

IOBT is expected to report earnings on Mar 04, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($1.12B) has a higher market cap than IOBT($20M). MLTX YTD gains are higher at: 19.803 vs. IOBT (-54.344). IOBT has higher annual earnings (EBITDA): -88.38M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. IOBT (30.7M). IOBT has less debt than MLTX: IOBT (18.1M) vs MLTX (75.7M). IOBT (0) and MLTX (0) have equivalent revenues.
IOBTMLTXIOBT / MLTX
Capitalization20M1.12B2%
EBITDA-88.38M-227.94M39%
Gain YTD-54.34419.803-274%
P/E RatioN/AN/A-
Revenue00-
Total Cash30.7M380M8%
Total Debt18.1M75.7M24%
TECHNICAL ANALYSIS
Technical Analysis
IOBTMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
90%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 5 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
IOBT
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRSVX54.620.50
+0.92%
T. Rowe Price Small-Cap Value
KTCCX12.910.05
+0.39%
DWS Science and Technology C
FDERX21.090.07
+0.33%
Federated Hermes Strategic Div Gr R
WLTTX12.560.01
+0.08%
Wilshire International Equity Instl
RSRFX10.78-0.07
-0.65%
Reaves Infrastructure Fund Class Inst

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with MLTX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
-4.17%
MLTX - IOBT
60%
Loosely correlated
+0.77%
KALA - IOBT
55%
Loosely correlated
-0.47%
NEVPF - IOBT
41%
Loosely correlated
N/A
IOVA - IOBT
31%
Poorly correlated
+2.35%
KURA - IOBT
30%
Poorly correlated
+1.85%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.77%
KALA - MLTX
84%
Closely correlated
-0.47%
NEVPF - MLTX
70%
Closely correlated
N/A
IOBT - MLTX
60%
Loosely correlated
-4.17%
XNCR - MLTX
50%
Loosely correlated
+0.17%
NUVL - MLTX
48%
Loosely correlated
+2.00%
More